Graves'Disease Presenting with Bilateral Acute Painful Proptosis, Ptosis, Ophthalmoplegia, & Visual Loss
Lancet 2:431-433, Leonard,T.J.K.,et al, 1984
Polymyositis & Dermatomyositis
NEJM 292:344, 1975, 292:403975., Bohan,A.,et al, 1975
Long-term Effects of Glucocorticoids on Function, Quality of Life, and Survival in Patients with Duchenne Muscular Dystrophy: A Prospective Cohort Study
Lancet 391:451-461, McDonald, C.M.,et al, 2018
Diagnosis and New Treatments in Muscular Dystrophies
JNNP 80:706-714, Manzur,A.Y. &Muntoni,F., 2009
Practice Parameter: Corticosteroid Treatment of Duchenne Dystrophy
Neurol 64:13-20, Moxley,R.T. III.,et al, 2005
Intermittent Prednisone Therapy in Duchenne Muscular Dystrophy
Arch Neurol 62:128-132, Beenakker,E.A.C.,et al, 2005
Duchenne Dystrophy:Randomized, Controlled Trial of Prednisone (18 months) & Azathioprine (12 months)
Neurol 43:520-527, Griggs,R.C.,et al, 1993
Prednisone in Duchenne Dystrophy, A Randomized, Controlled Trial Defining the Time Course & Dose Response
Arch Neurol 48:383-388, Griggs,R.C.,et al, 1991
A Comparison of Daily and Alternate-Day Prednisone Therapy in the Treatment of Duchenne Muscular Dystrophy
Arch Neurol 48:575-579, Fenichel,G.M.,et al, 1991
Long-Term Benefit from Prednisone Therapy in Duchenne Muscular Dystrophy
Neurol 41:1874-1877, Fenichel,G.M.,et al, 1991
Five Types of Dystrophy
Together with Other Conditions Producing Insidious Muscle Weakness-Table 1-Hospital Med p. 60., , 1850
IgG4-Related Orbital Inflammation
https://EyeWiki.org, Oct, Chelnis,J. & Gervasio,K.A., 2023
Cases with IgG4-related Ophthalmic Disease with Mass Lesions Surrounding the Optic Nerve
Am J Ophthalmol 25:101324, Hamaoka, S.,t al, 2022
The Tolosa-Hunt Syndrome
NJJP 71:577-582, Kline,L.B. & Hoyt,W.F., 2021
Young Woman with Orbital Pain and Diplopia
Neurol 94:e752-e757, Infante, R.,et al, 2020
A 22-Year-Old Man with Progressive Bilateral Visual Loss
Neurol 94:625-630, Yang, S.L.,et al, 2020
Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 379:2452-2461, Case 39-2018, 2018
Overview of IgG4-related Disease
UptoDate, July, Moutsopoulos,H.,et al, 2017
A 44-Year-Old Man with Eye, Kidney, and Brain Dysfunction
Ann Neurol 79:507-519, Vodopivec, I.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Tolosa-Hunt Syndrome - a Rare Cause of Headache and Ophthalmoplegia
Lancet 382:912, Zurawski, J. & Akhondi, H., 2013
Painful Ophthalmoplegia Following Dental Procedure
Neuroophthalmol 37:165-168, Simsek, I.,et al, 2013
Treatment of Ocular Symptoms in Myasthenia Gravis
Neurol 71:1335-1341, Bhanushali,M.J.,et al, 2008
Evidence Report: The Medical Treatment of Ocular Myasthenia (An Evidence-Based Review)
Neurol 68:2144-2149, Benatar,M. &Kaminski,H.J., 2007
Sarcoidosis: Clinical, Hormonal, and Magnetic Resonance Imaging (MRI) Manifestations of Hypothalamic-Pituitary Disease in 9 Patients and Review of the Literature
Medicine 86:259-268, Bihan,H.,et al, 2007
Immunosuppressive or Surgical Treatment for Ocular Myasthenia Gravis
Arch Neurol 64:1792-1794,1794, Chavis,P.S.,et al, 2007
Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy
Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007
Ocular Myasthenia: Diagnosis, Treatment and Pathogenesis
The Neurologist 12:231-239, Kusner,L.,et al, 2006
Multiple Cranial Nerve Palsies Associated with Type 2 Diabetes Mellitus
Singapore Med J 47:712-715, Singh, N.P.,et al, 2006
Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
The Tolosa-Hunt Syndrome
JNNP 71:577-582, Kline,L.B. &Hoyt,W.F., 2001
Treatment of Ocular Myasthenia
Arch Neurol 57:752-753, Kaminski,H.J.&Daroff,R.B., 2000
Treatment of Ocular Myasthenia With Corticosteroids
Arch Neurol 57:750-751,753, Agius,M.A., 2000
Dysthyroid Orbitopathy
Semin Neurol 20:43-54, Jacobson,D.M., 2000
Acute Rectus Muscle Palsy in Children as a Result of Orbital Myositis
J Pediatr 128:230-233, Pollard,F.,et al, 1996
Beneficial Effects of Corticosteroids on Ocular Myasthenia Gravis
ARch Neurol 53:802-804, Kupersmith,M.J.,et al, 1996
Gadopentetate Dimeglumine-Enhanced MR in the Diagnosis of the Tolosa-Hunt Syndrome
AJNR 16:942-944, Zournas,C.,et al, 1995
Extraocular Muscles in Graves Ophthalmopathy:Usefulness of T2 Relaxation Time Measurements
Radiology 190:857-862, Ohnishi,T.,et al, 1994
Visual Morbidity in Giant Cell Arteritis:Clinical Characteristics and Prognosis for Vision
Ophthalmology 101:1779-1785, Liu,G.T.,et al, 1994
Ocular Myasthenia:A Protean Disorder
Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994
Prolonged Paralysis Due to Nondepolarizing Neuromuscular Blocking Agents and Corticosteroids
Muscle & Nerve 17:647-654994., Barohn,R.J.,et al, 1994
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991
Use of Immunosuppressive Agents in the Treatment of Severe Ocular and Vascular Manifestations of Cogan's Syndrome
Am J Med 88:296-301, Allen,N.B.,et al, 1990
Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990
A Clinical Triad to Diagnose Paraneoplastic Retinopathy
Ann Neurol 28:162-167, Jacobson,D.M.,et al, 1990
Reflex Sympathetic Dystrophy, A Review
Arch Neurol 44:555-561, Schwartzman,R.J.&McLellan,T.L., 1987
Idiopathic Cranial Polyneuropathy
Brain 110:197-211, Juncos,J.L.&Beal,M.F., 1987
Cogan's Syndrome:18 Cases & a Review of the Literature
Mayo Clin Proc 61:344-361, Vollertsen,R.S.,et al, 1986